Suborning science for profit: Monsanto, glyphosate, and private science research misconduct

Leland Glenna and Analena Bruce

Research Policy, 2021, vol. 50, issue 7

Abstract: Using documents from a lawsuit filed against the agricultural chemical and biotechnology firm Monsanto (now Bayer), we document a private firm's efforts to distort the scientific peer-review process through ghostwriting, to orchestrate campaigns to retract journal articles, and to influence editorial decisions. The firm's apparent goal was to manipulate the regulatory process so that it could continue selling a product that the firm's own research indicated might be dangerous. The long-term impact has been to threaten the integrity of scientific peer review and public trust in science. The findings have implications for public-private research collaborations, the validity of private-science research, scientific journal policies on conflict-of-interest disclosures, and policies governing the role of private science in regulatory oversight.

Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0048733321000925
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:respol:v:50:y:2021:i:7:s0048733321000925

DOI: 10.1016/j.respol.2021.104290

Access Statistics for this article

Research Policy is currently edited by M. Bell, B. Martin, W.E. Steinmueller, A. Arora, M. Callon, M. Kenney, S. Kuhlmann, Keun Lee and F. Murray

More articles in Research Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu ().